Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2023-2030
Triton’s report insinuates that the cough syrup market in the Middle East and Africa is likely to witness a CAGR of 3.91% during the forecasting years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries evaluated in the region comprise:
•
United Arab Emirates
•
Saudi Arabia
•
Turkey
•
South Africa
•
Rest of Middle East & Africa
In the
Middle East and Africa, factors such as population growth, urbanization, and
changing lifestyles are spurring the demand for cough syrups. Additionally, an
increasing awareness of health and wellness, along with improved healthcare
access, is driving consumption. Furthermore, the region’s vulnerability to
respiratory illnesses due to environmental factors like dust and pollution is
also contributing to the demand for cough syrups. However, challenges persist,
including regulatory complexities, variations in healthcare infrastructure, and
affordability concerns for certain population segments.
South Africa leads with the
major share in the cough syrup market. The
Tobacco Free Kids Campaign in the country reports an annual death toll
exceeding 39,000 from tobacco-related diseases, emphasizing the grave health
risks tied to smoking. Consequently, those who smoke or encounter secondhand
smoke face an elevated likelihood of respiratory problems, such as chronic
coughs and infections. This has elevated the demand for cough syrups as
individuals seek relief from persistent coughing and its associated symptoms.
Furthermore,
cough syrups are a highly sought-after category among over-the-counter drugs in
South Africa. This demand is influenced by various factors, including the
widespread occurrence of respiratory ailments, seasonal fluctuations, and the
necessity for alleviating symptoms. Consumers frequently turn to cough syrups
to ease coughs, soothe throat irritation, and alleviate chest congestion.
Expectorants,
found commonly in cough syrups, aid in loosening and thinning mucus within the
airways, facilitating easier expulsion and clearance from the respiratory
system. They are often recommended for individuals experiencing productive
coughs, assisting in the elimination of excessive mucus from the lungs and air
passages. Respiratory problems and coughing can also be triggered by shifts in
environmental conditions, exposure to air pollution, and allergens.
The market is segmented based
on product type, age group, and distribution channel.
The product type includes expectorants, combination medicines, and cough
suppressants.
The companies in the given market
consist of Novartis AG, Reckitt Benckiser Group Plc, The Procter & Gamble
Company, Sanofi SA, Cipla Limited, Kenvue Inc, AstraZeneca Plc, and Acella
Pharmaceuticals LLC.
Novartis
AG, a Swiss-based corporation, operates in the pharmaceutical and eye care
sectors, specializing in the entire spectrum of activities related to
prescription and generic pharmaceutical products. Its product portfolio spans
a wide range of therapeutic areas, encompassing cancer, cardiovascular
diseases, dermatological conditions, neurological disorders, ophthalmic and
respiratory ailments, hematologic disorders, solid tumors, immunological
disorders, and infectious diseases. With a global presence, Novartis has
established subsidiaries and offices across multiple regions, including the
Middle East and Africa.
Key deliverables of the report:
· Market CAGR during the forecasting
years 2023-2030
· Detailed data highlighting key
insights, industry components, and market strategies
· Comprehensive information and
estimation of the cough syrup market revenue growth in the Middle East and
Africa and its influence on the parent market
· In-depth study of forthcoming trends
in consumer behavioral patterns
· A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
· A wide-ranging study of factors that
will challenge the Middle East and Africa cough syrup market’s growth during
the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE COUGH SYRUP MARKET
2.1.1. COVID-19
IMPACT
2.1.2. UKRAINE-RUSSIA
WAR IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. INDUSTRY
COMPONENTS
2.3.1. RAW
MATERIALS
2.3.2. MANUFACTURERS
2.3.3. DISTRIBUTORS
2.3.4. RETAILERS
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. COLLABORATIONS
2.5.2. PRODUCT
LAUNCHES
2.5.3. ACQUISITIONS
2.5.4. BUSINESS
DIVESTITURES & EXPANSIONS
2.6. MARKET
DRIVERS
2.6.1. HIGH
INCIDENCE OF RESPIRATORY AILMENTS
2.6.2. VULNERABILITY
TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION
2.6.3. INNOVATIONS
IN COUGH SYRUPS
2.7. MARKET
CHALLENGES
2.7.1. OVERDOSE
RISKS ASSOCIATED WITH COUGH SYRUPS
2.7.2. STRICT
REGULATORY REQUIREMENTS
2.7.3. INCREASING
COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS
2.8. MARKET
OPPORTUNITIES
2.8.1. SELF-MEDICATION
TRENDS INCREASE DEMAND FOR OTC DRUGS
2.8.2. HERBAL
COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE
2.8.3. EASE
OF PURCHASE OFFERED BY E-COMMERCE CHANNELS
2.8.4. AVAILABILITY
OF SUGAR-FREE COUGH SYRUPS
2.8.5. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.9. ANALYST
PERSPECTIVE
3. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET – BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS
3.2. COMBINATION
MEDICINES
3.3. EXPECTORANTS
4. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET – BY AGE GROUP
4.1. ADULTS
4.2. ADOLESCENTS
4.3. PEDIATRIC
5. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACIES
5.2. HOSPITAL
PHARMACIES
5.3. E-PHARMACIES
6. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET – BY COUNTRY OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.1.1. UNITED
ARAB EMIRATES COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2. TURKEY
6.2.1. TURKEY
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3. SAUDI
ARABIA
6.3.1. SAUDI
ARABIA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.4. SOUTH
AFRICA
6.4.1. SOUTH
AFRICA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5. REST
OF MIDDLE EAST & AFRICA
6.5.1. REST
OF MIDDLE EAST & AFRICA COUGH SYRUP MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. GSK
PLC
7.1.1. OVERVIEW
7.1.2. PRODUCT
PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. PFIZER
INC
7.2.1. OVERVIEW
7.2.2. PRODUCT
PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. NOVARTIS
AG
7.3.1. OVERVIEW
7.3.2. PRODUCT
PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. RECKITT
BENCKISER GROUP PLC
7.4.1. OVERVIEW
7.4.2. PRODUCT
PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. THE PROCTER
& GAMBLE COMPANY
7.5.1. OVERVIEW
7.5.2. PRODUCT
PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. SANOFI
SA
7.6.1. OVERVIEW
7.6.2. PRODUCT
PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. CIPLA LIMITED
7.7.1. OVERVIEW
7.7.2. PRODUCT
PORTFOLIO
7.7.3. KEY
STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. KENVUE
INC
7.8.1. OVERVIEW
7.8.2. PRODUCT
PORTFOLIO
7.8.3. KEY
STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. ASTRAZENECA
PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT
PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. ACELLA
PHARMACEUTICALS LLC
7.10.1. OVERVIEW
7.10.2. PRODUCT
PORTFOLIO
7.10.3. KEY
STRENGTHS
7.10.4. KEY
CHALLENGES
7.11. THE
HIMALAYA WELLNESS COMPANY
7.11.1. OVERVIEW
7.11.2. PRODUCT
PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. MERCK
KGAA
7.12.1. OVERVIEW
7.12.2. PRODUCT
PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. ABBOTT
LABORATORIES
7.13.1. OVERVIEW
7.13.2. PRODUCT
PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. GLENMARK
PHARMACEUTICALS LIMITED
7.14.1. OVERVIEW
7.14.2. PRODUCT
PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
7.15. DABUR
INDIA LTD
7.15.1. OVERVIEW
7.15.2. PRODUCT
PORTFOLIO
7.15.3. KEY
STRENGTHS
7.15.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 7: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 10: MIDDLE EAST
AND AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: INDUSTRY COMPONENTS
FIGURE 2: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 3: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)
FIGURE 6: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA
COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)
FIGURE 10: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 14: UNITED ARAB
EMIRATES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 15: TURKEY COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 16: SAUDI ARABIA COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: SOUTH AFRICA COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: REST OF MIDDLE EAST
& AFRICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)